YIJIAHE(SH:603666)2025-10-30 09:45Financial Performance - The company's operating revenue for the third quarter was ¥88,206,729.43, a decrease of 65.97% compared to the same period last year[4] - The total profit for the third quarter was -¥19,120,514.48, reflecting a decline of 583.29% year-on-year[4] - The net profit attributable to shareholders was -¥22,528,563.75, a decrease of 569.05% compared to the previous year[4] - The net cash flow from operating activities for the year-to-date was -¥83,098,125.98, representing a decline of 223.83%[4] - Basic earnings per share for the third quarter were -¥0.11, a decrease of 650.00% year-on-year[5] - The total operating revenue for the first three quarters of 2025 was CNY 355,953,375.72, a decrease of 11.2% compared to CNY 401,015,451.48 in the same period of 2024[24] - The net profit for the first three quarters of 2025 was -45,747,607.94 RMB, compared to -84,159,958.77 RMB in the same period of 2024, showing an improvement of approximately 45.3%[25] - Operating profit for the first three quarters of 2025 was -37,763,742.32 RMB, a significant improvement from -103,357,153.83 RMB in the previous year[25] - Total revenue from operating activities in the first three quarters of 2025 was 489,898,717.78 RMB, down from 647,234,427.70 RMB in 2024, representing a decrease of about 24.4%[27] - Basic and diluted earnings per share for the first three quarters of 2025 were both -0.21 RMB, an improvement from -0.40 RMB in the same period of 2024[26] - The company recorded a total comprehensive loss of -45,747,607.94 RMB for the first three quarters of 2025, compared to -82,571,339.78 RMB in 2024[26] - Investment income for the first three quarters of 2025 was 2,275,461.33 RMB, a significant recovery from a loss of -19,623,015.54 RMB in the previous year[25] - The company's financial expenses decreased significantly to 331,277.48 RMB in 2025 from 11,286,848.56 RMB in 2024, indicating improved cost management[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,179,511,816.11, down 5.83% from the end of the previous year[5] - The total liabilities as of September 30, 2025, were CNY 1,057,824,232.76, compared to CNY 1,208,981,529.36 at the end of 2024, indicating a decrease of 12.5%[22] - The total assets as of September 30, 2025, were CNY 3,179,511,816.11, down from CNY 3,376,416,720.65 at the end of 2024[20] - As of September 30, 2025, the total current assets were CNY 1,712,042,555.22, slightly down from CNY 1,733,680,967.18 at the end of 2024[20] - The company's cash and cash equivalents were CNY 282,234,705.17 as of September 30, 2025, compared to CNY 289,513,342.59 at the end of 2024[20] - The long-term equity investments increased to CNY 3,276,709.20 as of September 30, 2025, from CNY 1,043,131.51 at the end of 2024[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 25,107[11] - The largest shareholder, Zhu Fuyun, holds 49,145,400 shares, representing 23.91% of total shares[11] - The company repurchased 960,396 shares, reducing total share capital from 206,490,816 shares to 205,530,420 shares[14] - The registered capital decreased from 20,649.0816 million RMB to 20,553.042 million RMB after the share repurchase[15] - The company plans to use 2,599,038 repurchased shares for employee stock ownership plans or equity incentives[16] - The top 10 shareholders hold a combined total of 103,000,000 shares, accounting for approximately 50% of total shares[11] - The company has not disclosed any changes in the participation of top shareholders in margin trading or securities lending[13] - The shareholder Nanjing Ruibei Venture Capital Management Center (Limited Partnership) is associated with Zhu Fuyun[12] - The company has not identified any other significant relationships among the top shareholders[12] Operational Insights - The decline in operating revenue was primarily due to fewer project deliveries and revenue recognition during the reporting period[9] - The company reported a significant increase in losses from investments in joint ventures, contributing to the overall net loss[9] - The company plans to focus on improving cash flow management and reducing operational costs in the upcoming quarters[9] - Cash flow from operating activities for the first three quarters of 2025 was -83,098,125.98 RMB, compared to a positive cash flow of 67,107,718.14 RMB in the same period of 2024[27] - Cash flow from investment activities generated a net inflow of 20,108,149.38 RMB in 2025, a recovery from a net outflow of -40,819,110.00 RMB in 2024[28] - The company reported cash and cash equivalents at the end of the period amounting to 277,457,593.86 RMB, an increase from 157,165,411.41 RMB at the end of the previous year[28] Accounting Changes - The company has implemented changes in accounting policies effective January 1, 2024, resulting in a retrospective adjustment of CNY 5,201,707.39 for quality assurance fees[18] - The company is actively advancing the banking procedures related to the equity restructuring of its subsidiary, Tadao Medical[17]